| __timestamp | Pharming Group N.V. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 14182353 | 15635076 |
| Thursday, January 1, 2015 | 15503028 | 23943601 |
| Friday, January 1, 2016 | 16183585 | 23689111 |
| Sunday, January 1, 2017 | 22382849 | 41006114 |
| Monday, January 1, 2018 | 33038206 | 51379106 |
| Tuesday, January 1, 2019 | 31777040 | 32705593 |
| Wednesday, January 1, 2020 | 41464134 | 53274000 |
| Friday, January 1, 2021 | 67178053 | 85352000 |
| Saturday, January 1, 2022 | 52531000 | 51999000 |
| Sunday, January 1, 2023 | 68914000 | 59471000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Summit Therapeutics Inc. and Pharming Group N.V. have demonstrated significant investment in R&D, reflecting their strategic focus on advancing medical breakthroughs.
Summit Therapeutics Inc. has shown a robust increase in R&D expenses, peaking in 2021 with a 450% rise from 2014 levels. This surge underscores their aggressive pursuit of novel therapies, particularly in the field of antibiotics and rare diseases.
Pharming Group N.V., while maintaining a steady growth trajectory, saw a notable 380% increase in R&D spending by 2023 compared to 2014. Their focus on innovative treatments for rare diseases has been a driving force behind this growth.
Both companies exemplify the biotech industry's relentless drive towards innovation, with R&D investments serving as a testament to their future ambitions.
R&D Insights: How Amgen Inc. and Pharming Group N.V. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Summit Therapeutics Inc.
R&D Insights: How Summit Therapeutics Inc. and Halozyme Therapeutics, Inc. Allocate Funds
Research and Development Investment: Summit Therapeutics Inc. vs Alkermes plc
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Summit Therapeutics Inc. and MiMedx Group, Inc.
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Pharming Group N.V. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Pharming Group N.V. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.